AI drug firm Recursion moves from survival to industry domination, with an Nvidia union and first-of-its-kind M&A.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
News
The next generation of AI biotechs is here. Can they deliver on the hype?
“We’re in a frothy time,” acknowledges Alexandra Snyder, the head of R&D at Generate:Biomedicines. Generate is one of the AI-driven biotechs that make up a new generation of companies with huge funding, A-list science and […]
News
Listen: VC struggles, drug pricing negotiations, & Novo’s abrupt Wegovy decision
Why is Novo waiting for more CV outcomes data to bolster its case? How will we know if the government gets a good deal on drug pricing negotiations? Learn that… Click here to view original […]
News
25 million cavities and $9.8 billion: Study estimates the costs of removing fluoride from water
Researchers estimated 7.5% more U.S. children would get cavities, affecting 25.4 million additional teeth, if fluoridation were banned nationwide Click here to view original post Click Here to Publish/Feature Your Company or Product News with […]
